Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial

OBJECTIVE: To determine the efficacy and safety of dalteparin postoperative bridging treatment versus placebo for patients with atrial fibrillation or mechanical heart valves when warfarin is temporarily interrupted for a planned procedure. DESIGN: Prospective, double blind, randomised controlled tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovacs, Michael J, Wells, Philip S, Anderson, David R, Lazo-Langner, Alejandro, Kearon, Clive, Bates, Shannon M, Blostein, Mark, Kahn, Susan R, Schulman, Sam, Sabri, Elham, Solymoss, Susan, Ramsay, Tim, Yeo, Erik, Rodger, Marc A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188228/
https://www.ncbi.nlm.nih.gov/pubmed/34108229
http://dx.doi.org/10.1136/bmj.n1205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188228/
https://www.ncbi.nlm.nih.gov/pubmed/34108229
http://dx.doi.org/10.1136/bmj.n1205

Ejemplares similares